* Achieve Life Sciences Inc ACHV.OQ reported a quarterly
adjusted loss of 50 cents per share for the quarter ended in
March. The mean expectation of five analysts for the quarter was
for a loss of 69 cents per share.
* Reported revenue was zero; analysts expected zero.
* Achieve Life Sciences Inc's reported EPS for the quarter
was a
loss of 50 cents.
* The mean earnings estimate of analysts had risen by
about 18.8%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Achieve Life Sciences Inc shares had risen by 28.5% this
quarter and gained 256.7% so far this year.
* The company reported a quarterly loss of $8.99 million.
* Wall Street's median 12-month price target for Achieve
Life
Sciences Inc is $22.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data May
9 at 10:34 p.m. UTC. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2023 -0.69 -0.50 Beat
Dec. 31 2022 -0.83 -0.83 Met
Sep. 30 2022 -1.13 -1.35 Missed
Jun. 30 2022 -0.83 -1.08 Missed